Agreed. I'm watching this from the sidelines. There might be a small pop based on name change PR especially given this is OTC. If anyone wants to play that. Company has some ways to go to get house in order. I still like the ticker since it is undervalued IMO.
News 
Market Data 
Discover 
AI
